ID

34411

Descrizione

Non-interventional Study With Pomalidomide (Imnovid®); ODM derived from: https://clinicaltrials.gov/show/NCT02075996

collegamento

https://clinicaltrials.gov/show/NCT02075996

Keywords

  1. 17/01/19 17/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

17 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Multiple Myeloma NCT02075996

Eligibility Multiple Myeloma NCT02075996

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with relapsed or refractory multiple myeloma patients must have received at least two prior lines of treatment (induction therapy followed by stem cell transplantation ± maintenance therapy is considered one prior therapy) and must have progressed under the most recent therapy regimen
Descrizione

ID.1

Tipo di dati

boolean

adult male and female patients (at least 18 years with no upper age limit)
Descrizione

ID.2

Tipo di dati

boolean

written informed consent to data collection and pseudonymized data transfer
Descrizione

ID.3

Tipo di dati

boolean

the conditions of the pregnancy prevention programme must be fulfilled for all patients unless there is reliable evidence that the patient does not have childbearing potential (see summary of product characteristics imnovid®)
Descrizione

ID.4

Tipo di dati

boolean

other criteria according to summary of product characteristics imnovid®
Descrizione

ID.5

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
missing patient's informed consent
Descrizione

ID.6

Tipo di dati

boolean

pregnant or breast-feeding women
Descrizione

ID.7

Tipo di dati

boolean

male patients, not capable of complying the required preventive measures (see summary of product characteristics imnovid®)
Descrizione

ID.8

Tipo di dati

boolean

other criteria according to summary of product characteristics imnovid®
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Multiple Myeloma NCT02075996

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with relapsed or refractory multiple myeloma patients must have received at least two prior lines of treatment (induction therapy followed by stem cell transplantation ± maintenance therapy is considered one prior therapy) and must have progressed under the most recent therapy regimen
boolean
ID.2
Item
adult male and female patients (at least 18 years with no upper age limit)
boolean
ID.3
Item
written informed consent to data collection and pseudonymized data transfer
boolean
ID.4
Item
the conditions of the pregnancy prevention programme must be fulfilled for all patients unless there is reliable evidence that the patient does not have childbearing potential (see summary of product characteristics imnovid®)
boolean
ID.5
Item
other criteria according to summary of product characteristics imnovid®
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
missing patient's informed consent
boolean
ID.7
Item
pregnant or breast-feeding women
boolean
ID.8
Item
male patients, not capable of complying the required preventive measures (see summary of product characteristics imnovid®)
boolean
ID.9
Item
other criteria according to summary of product characteristics imnovid®
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial